Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

394 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical outcome after bleeding events following coronary stenting in patients with and without comorbid peripheral arterial disease.
Pinxterhuis TH, Ploumen EH, Kok MM, Schotborgh CE, Anthonio RL, Roguin A, Danse PW, Benit E, Aminian A, Hartmann M, Linssen GCM, Geelkerken RH, Doggen CJM, von Birgelen C. Pinxterhuis TH, et al. Among authors: von birgelen c. Cardiovasc Interv Ther. 2024 Dec 19. doi: 10.1007/s12928-024-01073-7. Online ahead of print. Cardiovasc Interv Ther. 2024. PMID: 39699832
Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials.
Ploumen EH, Pinxterhuis TH, Zocca P, Roguin A, Anthonio RL, Schotborgh CE, Benit E, Aminian A, Danse PW, Doggen CJM, von Birgelen C, Kok MM. Ploumen EH, et al. Among authors: von birgelen c. Cardiovasc Diabetol. 2021 Oct 30;20(1):217. doi: 10.1186/s12933-021-01405-4. Cardiovasc Diabetol. 2021. PMID: 34717627 Free PMC article.
Outcome after percutaneous coronary intervention with contemporary stents in patients with concomitant peripheral arterial disease: A patient-level pooled analysis of four randomized trials.
Pinxterhuis TH, Ploumen EH, Zocca P, Doggen CJM, Schotborgh CE, Anthonio RL, Roguin A, Danse PW, Benit E, Aminian A, Stoel MG, Linssen GCM, Geelkerken RH, von Birgelen C. Pinxterhuis TH, et al. Among authors: von birgelen c. Atherosclerosis. 2022 Aug;355:52-59. doi: 10.1016/j.atherosclerosis.2022.05.002. Epub 2022 May 20. Atherosclerosis. 2022. PMID: 35641327 Free article. Clinical Trial.
Risk of bleeding after percutaneous coronary intervention and its impact on further adverse events in clinical trial participants with comorbid peripheral arterial disease.
Pinxterhuis TH, Ploumen EH, Zocca P, Doggen CJM, Schotborgh CE, Anthonio RL, Roguin A, Danse PW, Benit E, Aminian A, Stoel MG, Linssen GCM, Geelkerken RH, von Birgelen C. Pinxterhuis TH, et al. Among authors: von birgelen c. Int J Cardiol. 2023 Mar 1;374:27-32. doi: 10.1016/j.ijcard.2022.12.009. Epub 2022 Dec 7. Int J Cardiol. 2023. PMID: 36496036 Free article.
First myocardial infarction in patients with premature coronary artery disease: insights into patient characteristics and outcome after treatment with contemporary stents.
Pinxterhuis TH, Ploumen EH, Doggen CJM, Hartmann M, Schotborgh CE, Anthonio RL, Roguin A, Danse PW, Benit E, Aminian A, Linssen GCM, von Birgelen C. Pinxterhuis TH, et al. Among authors: von birgelen c. Eur Heart J Acute Cardiovasc Care. 2023 Nov 16;12(11):774-781. doi: 10.1093/ehjacc/zuad098. Eur Heart J Acute Cardiovasc Care. 2023. PMID: 37619976 Free PMC article.
Comparison of 3 biodegradable polymer and durable polymer-based drug-eluting stents in all-comers (BIO-RESORT): rationale and study design of the randomized TWENTE III multicenter trial.
Lam MK, Sen H, Tandjung K, van Houwelingen KG, de Vries AG, Danse PW, Schotborgh CE, Scholte M, Löwik MM, Linssen GC, Ijzerman MJ, van der Palen J, Doggen CJ, von Birgelen C. Lam MK, et al. Among authors: von birgelen c. Am Heart J. 2014 Apr;167(4):445-51. doi: 10.1016/j.ahj.2013.11.014. Epub 2014 Jan 6. Am Heart J. 2014. PMID: 24655691 Free article. Review.
Clinical outcome of patients with implantation of second-generation drug-eluting stents in the right coronary ostium: insights from 2-year follow-up of the TWENTE trial.
Lam MK, Sen H, Tandjung K, Löwik MM, Basalus MW, Mewes JC, Stoel MG, van Houwelingen KG, Linssen GC, Ijzerman MJ, Doggen CJ, von Birgelen C. Lam MK, et al. Among authors: von birgelen c. Catheter Cardiovasc Interv. 2015 Mar;85(4):524-31. doi: 10.1002/ccd.25518. Epub 2014 May 8. Catheter Cardiovasc Interv. 2015. PMID: 24753036 Clinical Trial.
Three-year clinical outcome after treatment of chronic total occlusions with second-generation drug-eluting stents in the TWENTE trial.
van Houwelingen KG, Sen H, Lam MK, Tandjung K, Löwik MM, de Man FH, Louwerenburg JH, Stoel MG, Hartmann M, Linssen GC, Doggen CJ, von Birgelen C. van Houwelingen KG, et al. Among authors: von birgelen c. Catheter Cardiovasc Interv. 2015 Feb 15;85(3):E76-82. doi: 10.1002/ccd.25713. Epub 2014 Nov 1. Catheter Cardiovasc Interv. 2015. PMID: 25339110 Clinical Trial.
Three-year clinical outcome of patients with bifurcation treatment with second-generation Resolute and Xience V stents in the randomized TWENTE trial.
Lam MK, Sen H, van Houwelingen KG, Löwik MM, van der Heijden LC, Kok MM, de Man FH, Linssen GC, Tandjung K, Doggen CJ, von Birgelen C. Lam MK, et al. Among authors: von birgelen c. Am Heart J. 2015 Jan;169(1):69-77. doi: 10.1016/j.ahj.2014.10.011. Epub 2014 Oct 25. Am Heart J. 2015. PMID: 25497250 Clinical Trial.
394 results